- Home
- HOUR vs GLSI Comparison
HOUR vs GLSI Comparison
Compare HOUR & GLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOUR
- GLSI
- Stock Information
- Founded
- HOUR 2015
- GLSI 2006
- Country
- HOUR United States
- GLSI United States
- Employees
- HOUR N/A
- GLSI N/A
- Industry
- HOUR Catalog/Specialty Distribution
- GLSI Biotechnology: Pharmaceutical Preparations
- Sector
- HOUR Consumer Discretionary
- GLSI Health Care
- Exchange
- HOUR Nasdaq
- GLSI Nasdaq
- Market Cap
- HOUR 125.8M
- GLSI 143.4M
- IPO Year
- HOUR 2022
- GLSI 2020
- Fundamental
- Price
- HOUR $2.19
- GLSI $12.87
- Analyst Decision
- HOUR
- GLSI Strong Buy
- Analyst Count
- HOUR 0
- GLSI 1
- Target Price
- HOUR N/A
- GLSI $38.00
- AVG Volume (30 Days)
- HOUR 5.3M
- GLSI 43.0K
- Earning Date
- HOUR 11-12-2024
- GLSI 11-14-2024
- Dividend Yield
- HOUR N/A
- GLSI N/A
- EPS Growth
- HOUR N/A
- GLSI N/A
- EPS
- HOUR 0.05
- GLSI N/A
- Revenue
- HOUR $143,314,112.00
- GLSI N/A
- Revenue This Year
- HOUR $39.97
- GLSI N/A
- Revenue Next Year
- HOUR N/A
- GLSI N/A
- P/E Ratio
- HOUR $43.32
- GLSI N/A
- Revenue Growth
- HOUR 15.71
- GLSI N/A
- 52 Week Low
- HOUR $0.83
- GLSI $8.00
- 52 Week High
- HOUR $6.90
- GLSI $21.44
- Technical
- Relative Strength Index (RSI)
- HOUR 51.04
- GLSI 51.89
- Support Level
- HOUR $2.15
- GLSI $11.50
- Resistance Level
- HOUR $2.56
- GLSI $12.84
- Average True Range (ATR)
- HOUR 0.35
- GLSI 0.90
- MACD
- HOUR -0.06
- GLSI 0.09
- Stochastic Oscillator
- HOUR 9.71
- GLSI 59.49
About HOUR Hour Loop Inc.
Hour Loop Inc is a technology-enabled consumer products company that uses machine learning and data analytics to design, develop, market, and sell products. Hour Loop predominantly operates through online retail channels such as Amazon, Walmart, and Hourloop.com. The Company, as an Internet marketplace seller, sells products in multiple categories, including home/garden decor, toys, kitchenware, apparel, and electronics. It has only one segment, which is online retail (e-commerce).
About GLSI Greenwich LifeSciences Inc.
Greenwich LifeSciences Inc is a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery. Its Product Candidates include; GP2, a HER2/neu transmembrane peptide that elicits a targeted immune response against HER2/neu-expressing cancers, GM-CSF Immunoadjuvant has been shown to enhance monocyte and neutrophil cytotoxicity against melanoma tumor cells and to enhance activity-dependent cellular cytotoxicity of monocytes and neutrophils against targets coated with the anti-ganglioside antibodies, and Cancer immunotherapy seeks to stimulate an individual's immune system to selectively attack cancer cells to inhibit the spread of cancer.